| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $569K | -51.7% |
| SG&A Expense | $703K | -67.1% |
| Operating Income | -$1.3M | +61.7% |
| Net Income | -$1.3M | +61.8% |
| EPS (Basic) | $0.07 | -69.6% |
| EPS (Diluted) | $0.07 | -69.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230K | -20.1% |
| Current Assets | $337K | +1.8% |
| Total Assets | $339K | +1.8% |
| Current Liabilities | $72K | -68.3% |
| Stockholders' Equity | -$267K | -351.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | -58.5% |
| Capital Expenditures | $2K | +0.0% |
| Investing Cash Flow | -$2K | +0.0% |
| Financing Cash Flow | $1.1M | +27.8% |
| Free Cash Flow | -$1.2M | -58.3% |